The quality of evidence is downgraded by study limitations (unclear allocation concealment), by inconsistency (unexplained variability in results), and by imprecise results (wide confidence intervals).
A Cochrane review included 4 studies with a total of 494 subjects. The proportion of participants who had achieved a therapeutic INR by day 5 was higher with 10-mg warfarin nomogram compared with 5-mg warfarin normogram (table ), although there was substantial heterogeneity (I2 = 90%). A sensitivity analysis was performed using the random-effects model, and no difference was observed (RR 1.06, 95% CI 0.52 to 2.16). Each study was analyzed separately because it was not possible to perform a subgroup analysis. One study (n=201) showed significant benefit of a 10-mg warfarin nomogram for the proportion of outpatients with VTE who had achieved a therapeutic INR by day 5 (RR 1.78, 95% CI 1.41 to 2.25; NNTB = 3, 95% CI 2 to 4); another study (n=132) showed significant benefit of a 5-mg warfarin nomogram in outpatients with VTE (RR 0.58, 95% CI 0.36 to 0.93; NNTB = 5, 95% CI 3 to 28); the third study (n=50) showed no difference (RR 1.08, 95% CI 0.65 to 1.80). No difference was observed in recurrent venous thromboembolism, in major bleeding, or in minor bleeding (table ).
| Outcome | Participnats (studies) | Assumed risk (5-mg warfarin nomogram) | Corresponding risk (10-mg warfarin nomogram) | RR (95% CI) |
|---|---|---|---|---|
| *fall in hemoglobin of > 20 g/L or transfusion of 2 or more units of red cells | ||||
| Therapeutic INR | 383 (3) | 473 per 1000 | 601 per 1000 (497 to 729) | 1.27 (1.05 to 1.54) |
| Recurrent venous thromboembolism at 90 days | 312 (2) | 17 per 1000 | 25 per 1000 (7 to 95) | 1.48 (0.39 to 5.56) |
| Major bleeding at 14–90 days* | 494 (4) | 17 per 1000 | 16 per 1000 (4 to 58) | 0.97 (0.27 to 3.51) |
| Minor bleeding at 14–90 days | 243 (2) | 50 per 1000 | 26 per 1000 (8 to 92) | 0.52 (0.15 to 1.83) |
Acute thromboembolism is treated with LMWH together with warfarin dose titration. LMWH treatment is effective and safe, and thus there is no hurry with warfarin titration.
NoteDate of latest search: